摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-((S)-3-Amino-pyrrolidin-1-yl)-6-fluoro-1-(2-fluoro-1,1-dimethyl-ethyl)-5-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid | 138668-39-0

中文名称
——
中文别名
——
英文名称
7-((S)-3-Amino-pyrrolidin-1-yl)-6-fluoro-1-(2-fluoro-1,1-dimethyl-ethyl)-5-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
英文别名
7-[(3S)-3-aminopyrrolidin-1-yl]-6-fluoro-1-(2-fluoro-1,1-dimethyl-ethyl)-5-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid;7-[(3S)-3-aminopyrrolidin-1-yl]-6-fluoro-1-(1-fluoro-2-methylpropan-2-yl)-5-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
7-((S)-3-Amino-pyrrolidin-1-yl)-6-fluoro-1-(2-fluoro-1,1-dimethyl-ethyl)-5-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid化学式
CAS
138668-39-0
化学式
C18H22F2N4O3
mdl
——
分子量
380.394
InChiKey
URMPNTFAJSVTGR-JTQLQIEISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    99.8
  • 氢给体数:
    2
  • 氢受体数:
    9

反应信息

点击查看最新优质反应信息

文献信息

  • Fluoronaphthyridines as antibacterial agents. 4. Synthesis and structure-activity relationships of 5-substituted 6-fluoro-7-(cycloalkylamino)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids
    作者:D. Bouzard、P. Di Cesare、M. Essiz、J. P. Jacquet、B. Ledoussal、P. Remuzon、R. E. Kessler、J. Fung-Tomc
    DOI:10.1021/jm00081a013
    日期:1992.2
    A series of 5-substituted-6-fluoro-7-(cycloalkylamino)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids have been prepared and tested for their in vitro and in vivo antibacterial activities. The 5-methyl group gave better in vitro activity with the 1-cyclopropyl appendage, but poorer activity with the 1-tert-butyl moiety. With the 1-(2,4-difluorophenyl) substitution, the influence of the 7-cycloalkylamino group was determinant: a (3S)-3-amino-pyrrolidine was shown to enhance greatly the in vitro and in vivo activity of the 5-methyl derivative. Compound 33 (BMY 43748) was selected as a promising candidate for an improved therapeutic agent.
查看更多